In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. GenMark Diagnostics is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. GenMark?s ePlex?: The True Sample-to-Answer Solution? is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. At GenMark, we?re changing the diagnostics landscape, combining out-of-the-box thinkers and game-changing technology to revolutionize patient care. Mission:?GenMark Dx?s missionGenMark Dx?s mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplexed molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies. At GenMark, we?re changing the molecular diagnostics landscape, combining ?out-of-the-box? thinkers with game changing technology to revolutionize patient care.
501 to 1000 Employees
TypeCompany - Public
Revenue$10 to $25 million (USD)
IndustryBiotech & Pharmaceuticals
Competitors?Quidel, Alere, DNA Electronics
Founded2010